Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the third quarter of fiscal year 2019 after the market close on Wednesday, November 6, 2019.
October 24, 2019
· 1 min read